Treatments for Opioid Use Disorder Among Pregnant and Reproductive-aged Women
Overview
Affiliations
The increased prevalence of opioid use disorder and access to medical insurance is subsequently increasing the likelihood that medical professionals will encounter individuals with opioid use disorder. Sharp increases in opioid use disorder among women mean that obstetricians, gynecologists, and other reproductive medicine providers may be especially likely to encounter such patients. Medical professionals' understanding of treatment for opioid use disorder and their roles in their patients' treatment may increase referrals to treatment, reduce stigma, and improve the quality of medical care. Treatment for opioid use disorder falls into four overlapping domains: medication management, medical care, behavioral/mental health care, and psychosocial support. In this review, we discuss these domains with an emphasis on pregnant women and women of reproductive age. Treatment for opioid use disorder is most effective when all providers coordinate care in an informed, nonjudgmental, patient-centered approach.
Promoting Innovation in State and Territorial Maternal and Child Health Policymaking.
Akbarali S, Dronamraju R, Simon J, Echols A, Collins S, Kaeberle B Matern Child Health J. 2023; 27(Suppl 1):5-13.
PMID: 37792151 PMC: 10692248. DOI: 10.1007/s10995-023-03779-1.
Short V, Hand D, Pyfer L, Steiger H, Gannon M, Jaffe G Womens Health Rep (New Rochelle). 2023; 3(1):998-1005.
PMID: 36636314 PMC: 9811839. DOI: 10.1089/whr.2022.0057.
Washio Y, Hayashi Y, Atreyapurapu S, Chang K, Ma T, Howard B Subst Use Misuse. 2022; 57(8):1257-1272.
PMID: 35582861 PMC: 10083725. DOI: 10.1080/10826084.2022.2076878.
Preis H, Whitney C, Kocis C, Lobel M PEC Innov. 2022; 1.
PMID: 35465253 PMC: 9020232. DOI: 10.1016/j.pecinn.2022.100030.
Forray A, Mele A, Byatt N, Tobon A, Gilstad-Hayden K, Hunkle K PLoS One. 2022; 17(1):e0261751.
PMID: 35025898 PMC: 8758001. DOI: 10.1371/journal.pone.0261751.